Jefferson Capital (JCAP) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
29 Nov, 2025Management team and governance
Board initially consists of seven directors, with staggered three-year terms across three classes.
JCF Stockholders have the right to designate up to four directors as long as they hold at least 50% of outstanding common stock, with decreasing representation as their ownership declines.
JCF Stockholders retain exclusive rights to fill vacancies for their designated directors and to have a representative on each board committee, subject to independence requirements.
The company will utilize all available “controlled company” exceptions to stock exchange governance standards unless waived by JCF Stockholders.
Certain major corporate actions require JCF Stockholder consent as long as they hold at least 10% of common stock.
Offering details and pricing
The offering consists of 625,000 shares sold by the company and 9,375,000 shares sold by selling stockholders, with an additional 1,500,000 shares available as an option for underwriters.
Jefferies LLC and Keefe, Bruyette & Woods, Inc. act as joint lead underwriters and representatives.
Up to 5% of the firm shares are reserved for a directed share program for eligible directors, officers, employees, and business partners.
Shares are to be listed on the Nasdaq Global Select Market, subject to official notice of issuance.
Underwriters and syndicate
The underwriting syndicate includes Jefferies LLC, Keefe, Bruyette & Woods, Inc., Citizens JMP Securities, Raymond James & Associates, Truist Securities, Capital One Securities, DNB Markets, Regions Securities, Synovus Securities, FHN Financial Securities, and ING Financial Markets.
Underwriters have standard indemnification and contribution rights, and the agreement includes customary lock-up provisions for the company and selling stockholders.
Latest events from Jefferson Capital
- Record collections, revenue, and efficiency ratios set strong momentum for 2026.JCAP
Q4 202512 Mar 2026 - Strong financial growth, leading market share, and a secondary offering with a concurrent share repurchase.JCAP
Registration Filing5 Jan 2026 - Strong growth, efficiency, and market leadership in consumer receivables; IPO to fund expansion.JCAP
Registration Filing18 Dec 2025 - Strong growth, high efficiency, and market leadership define this controlled company's IPO.JCAP
Registration Filing29 Nov 2025 - Strong financial growth, market leadership, and IPO to fund expansion with J.C. Flowers retaining control.JCAP
Registration Filing29 Nov 2025 - Revenue, net income, and collections surged, led by Conn's acquisition and sector-leading efficiency.JCAP
Q2 202523 Nov 2025 - Record collections, major acquisitions, and expanded credit facility fueled strong growth.JCAP
Q3 202515 Nov 2025